Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Herbal Compound Farnesiferol C Exerts Antiangiogenic and Antitumor Activity and Targets Multiple Aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) Signaling Cascades

Jae-Ho Lee, Sun Choi, Yoonji Lee, Hyo-Jeong Lee, Kwan-Hyun Kim, Kyoo-Seok Ahn, Hyunsoo Bae, Hyo-Jung Lee, Eun-Ok Lee, Kwang-Seok Ahn, Shi Yong Ryu, Junxuan Lü and Sung-Hoon Kim
Jae-Ho Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sun Choi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoonji Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyo-Jeong Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kwan-Hyun Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyoo-Seok Ahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyunsoo Bae
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyo-Jung Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eun-Ok Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kwang-Seok Ahn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shi Yong Ryu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junxuan Lü
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sung-Hoon Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-09-0775 Published February 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: January 2010 to January 2021

AbstractFull-text HTMLPDF
Total378931142268

Cited By

Article Information

Volume 9, Issue 2, pp. 389-399

DOI 
https://doi.org/10.1158/1535-7163.MCT-09-0775
PubMed 
20103598

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received August 21, 2009
  • Revision received November 11, 2009
  • Accepted November 24, 2009
  • Published first January 26, 2010.

Article Versions

  • Previous version (January 26, 2010 - 08:20).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2010 American Association for Cancer Research.

Author Information

  1. Jae-Ho Lee1,
  2. Sun Choi2,
  3. Yoonji Lee2,
  4. Hyo-Jeong Lee1,3,
  5. Kwan-Hyun Kim1,
  6. Kyoo-Seok Ahn1,
  7. Hyunsoo Bae1,
  8. Hyo-Jung Lee1,
  9. Eun-Ok Lee1,
  10. Kwang-Seok Ahn1,
  11. Shi Yong Ryu4,
  12. Junxuan Lü3 and
  13. Sung-Hoon Kim1,3
  1. Authors' Affiliations: 1Cancer Preventive Material Development Research Center, College of Oriental Medicine, Kyunghee University and 2College of Pharmacy, National Core Research Center for Cell Signaling and Drug Discovery, Ewha Womans University, Seoul, Korea; 3The Hormel Institute, University of Minnesota, Austin, Minnesota; and 4Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, Korea
  1. Corresponding Authors:
    Sung-Hoon Kim, College of Oriental Medicine, Kyunghee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 131-701, Republic of Korea. E-mail: sungkim7{at}khu.ac.kr or Junxuan Lü, Hormel Institute, University of Minnesota, 801 16th Avenue Northeast, Austin, MN 55912. Phone: 507-437-9680; Fax: 507-437-9606. E-mail: jlu{at}hi.umn.edu
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 9 (2)
February 2010
Volume 9, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Herbal Compound Farnesiferol C Exerts Antiangiogenic and Antitumor Activity and Targets Multiple Aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) Signaling Cascades
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Herbal Compound Farnesiferol C Exerts Antiangiogenic and Antitumor Activity and Targets Multiple Aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) Signaling Cascades
Jae-Ho Lee, Sun Choi, Yoonji Lee, Hyo-Jeong Lee, Kwan-Hyun Kim, Kyoo-Seok Ahn, Hyunsoo Bae, Hyo-Jung Lee, Eun-Ok Lee, Kwang-Seok Ahn, Shi Yong Ryu, Junxuan Lü and Sung-Hoon Kim
Mol Cancer Ther February 1 2010 (9) (2) 389-399; DOI: 10.1158/1535-7163.MCT-09-0775

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Herbal Compound Farnesiferol C Exerts Antiangiogenic and Antitumor Activity and Targets Multiple Aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) Signaling Cascades
Jae-Ho Lee, Sun Choi, Yoonji Lee, Hyo-Jeong Lee, Kwan-Hyun Kim, Kyoo-Seok Ahn, Hyunsoo Bae, Hyo-Jung Lee, Eun-Ok Lee, Kwang-Seok Ahn, Shi Yong Ryu, Junxuan Lü and Sung-Hoon Kim
Mol Cancer Ther February 1 2010 (9) (2) 389-399; DOI: 10.1158/1535-7163.MCT-09-0775
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • PX-478 Radiosensitization in Pancreatic Cancer
  • Metronomic Gemcitabine Inhibits Pancreatic Cancer
  • p53-Deficient Cells Are More Sensitive to Plk1 Inhibitor
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement